Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05839652 · ClinicalTrials.gov registry record · Phase 4
Treatment of Orthostatic Hypotension in SCI
A Phase 4 study of Hypotension, sponsored by James J. Peters Veterans Affairs Medical Center.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 25
- Enrollment target
- 2
- Study locations
NCT05839652 is a Phase 4 study of Hypotension that is actively recruiting participants, run by James J. Peters Veterans Affairs Medical Center. The registered enrollment target is 25 participants, below the 78-participant average among 12 other Hypotension trials with a reported enrollment target (68% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05839652, a Phase 4 study of Hypotension, is actively recruiting participants, sponsored by James J. Peters Veterans Affairs Medical Center.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 25 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to identify the effects of non-pharmacological and pharmacological anti-hypotensive treatment interventions on orthostatic hemodynamic responses, symptoms of autonomic dysreflexia and orthostatic hypotension, and levels of fatigue and comfort in hypotensive individuals with SCI.
Conditions Studied
Interventions
- DRUG Midodrine Hydrochloride
Study Locations (2)
New Jersey
- Kessler Foundation - West Orange
New York
- James J Peters VA Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-07-01 |
| Est. Completion | 2026-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05839652
The ClinicalTrials.gov registry entry for NCT05839652 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 78-participant average among 12 other Hypotension trials with a reported enrollment target (68% lower). The listed sponsor is James J. Peters Veterans Affairs Medical Center, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypotension appearing as the primary indexed condition, and to 1 intervention - of which Midodrine Hydrochloride is the first listed.
NCT05839652 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New Jersey, New York.
Frequently Asked Questions
What is clinical trial NCT05839652 about?
NCT05839652 is a clinical study titled "Treatment of Orthostatic Hypotension in SCI". The purpose of this study is to identify the effects of non-pharmacological and pharmacological anti-hypotensive treatment interventions on orthostatic hemodynamic responses, symptoms of autonomic dysreflexia and orthostatic hypotension, and levels of fatigue and comfort in hypotensive individuals w...
What is the current status of trial NCT05839652?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2023-07-01. Estimated completion is 2026-06-30.
What conditions does trial NCT05839652 study?
This clinical trial studies the following conditions: Hypotension.
What interventions are being tested in trial NCT05839652?
The interventions under investigation include: Midodrine Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT05839652?
This trial is sponsored by James J. Peters Veterans Affairs Medical Center, which has 39 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05839652 being conducted?
This trial has 2 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypotension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study to Determine the Pharmacokinetics and Pharmacodynamic Effects of Phenylephrine on BP Via IV
RECRUITING · Phase 4
-
Evaluating Fluid Strategies in Thoracic Surgery Patients Utilizing a Goal Directed Approach
COMPLETED · Phase 4
-
The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI)
RECRUITING · NA
-
Spinal Cord Transcutaneous Stimulation Effect on Blood Pressure in Acute Spinal Cord Injury (SCI)
RECRUITING · NA
-
TSCS for Acute SCI
RECRUITING · NA
-
Noninvasive Continuous BP Monitoring in Newborns Based on Pulsatile Signal Morphological Features Using NIRS
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.